A semi-automated software program to assess the impact of second reads in prostate MRI for equivocal lesions: results from a UK tertiary referral centre.

PURPOSE: To investigate the utility of a prostate magnetic resonance imaging (MRI) second read using a semi-automated software program in the one-stop clinic, where patients undergo multiparametric MRI, review and biopsy planning in one visit. We looked at concordance between readers for patients with equivocal scans and the possibility for biopsy deferral in this group. METHODS: We present data from 664 consecutive patients. Scans were reported by seven different expert genitourinary radiologists using dedicated software (MIM®) and a Likert scale. All scans were rescored by another expert genitourinary radiologist using a customised workflow for second reads that includes annotated biopsy contours for accurate visual targeting. The number of scans in which a biopsy could have been deferred using biopsy results and prostate specific antigen density was assessed. Gleason score ≥ 3 + 4 was considered clinically significant disease. Concordance between first and second reads for equivocal scans (Likert 3) was evaluated. RESULTS: A total of 209/664 (31%) patients scored Likert 3 on first read, 128 of which (61%) were concordant after second read. 103/209 (49%) of patients with Likert 3 scans were biopsied, with clinically significant disease in 31 (30%) cases. Considering Likert 3 scans that were both downgraded and biopsied using the workflow-generated biopsy contours, 25/103 (24%) biopsies could have been deferred. CONCLUSIONS: Implementing a semi-automated workflow for accurate lesion contouring and targeting biopsies is helpful during the one-stop clinic. We observed a reduction of indeterminate scans after second reading and almost a quarter of biopsies could have been deferred, reducing the potential biopsy-related side effects.

A diagnostic tool for basic daily quality assurance of a Tomotherapy Hi*Art machine.

To investigate and evaluate the use of an in-house developed diagnostic software tool using the imaging detector data for a quick daily quality assurance check of the output (dose) and lateral profile (cone) of a tomotherapy Hi*Art system. The Hi*Art treatment system is a radiation therapy machine for delivering intensity modulated radiation therapy (IMRT) in a helical fashion with an integrated CT scanner used for improved patient positioning before treatment. Since the system was developed specifically for IMRT, flat fields can be obtained by modulating the beam and therefore the flattening filter could be omitted. Because of this, the field has a cone-like profile in both lateral and transversal directions. Patients are treated in a helical fashion with a tight pitch and a constant gantry rotation speed, while modulation is performed by a binary MLC. Consequently dose output per time-unit (dose rate) as well as the shape of the cone-profile are very important for correct patient treatment and should be closely monitored. However, using the company-provided initial tools and conventional dosimetry, this can be a time consuming daily procedure. The aim of this work is to develop a fast, automated method of quality assurance based on the detector signal. A software tool called "tomocheck" running on the operation station has been developed to evaluate the output (dose rate) and the lateral cone profile (energy) of the Hi*Art system, comparing actual output and cone profile with a reference (previously approved against ionization chamber measurements). This is done by using the data of the 640 on-board detector array that are directly retrieved and processed after a specific QA procedure. The detector file consists of the CT detector data and the three monitoring dose chamber readings over a time period of 200 sec. To evaluate the method, the system was benchmarked against ionization chamber measurements and classical IMRT QA methods. Action levels (final status "NOT ACCEPTED") for dose ratio as well as the cone ratio are set to +/- 2%. The QA tool was introduced for daily QA in May 2007. For the following 24 months, a total of 931 morning checks was made on both tomotherapy machines. In 42 cases the check status was "NOT ACCEPTED". In 34 cases the dose ratio (DR) was out of tolerance. The corrected cone ratio (CCR) was outside of specification tolerance in 8 cases. The tomocheck data was related to the ionization chamber measurements for the IMRT plan indicating a close relationship between the CCR and the off-axis measurements. Average dose ratio against the mean value of the on- and off-axis IC measurement indicates that this parameter is a good interpretation of the dose output. This tool makes it possible to perform an easy-to-use and fast basic daily quality assurance check featuring an output as well as an energy evaluation. Ideally this tool should offer also the combined dosimetry check of jaw width, couch speed, leaf latency, output, leaf/gantry synchrony, and lasers. This will be investigated in the future.